Jennifer Speth

Dr. Jennifer Speth


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
HBHal E Broxmeyer
Hal E Broxmeyer
JHJonathan Hoggatt
Jonathan Hoggatt
HOHeather O’Leary
Heather O’Leary
CMCharlie Mantel
Charlie Mantel
BCBrahmananda R Chitteti
Brahmananda R Chitteti
TCTimothy B Campbell
Timothy B Campbell

6 April 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
EBEmilie Bourdonnay
Emilie Bourdonnay
ZZZbigniew Zasłona
Zbigniew Zasłona
LPLoka Raghu Kumar Penke
Loka Raghu Kumar Penke
JSJennifer Speth
Jennifer Speth
DSDaniel J. Schneider
Daniel J. Schneider
MPMarc Peters-Golden
Marc Peters-Golden
JAK-STAT signaling mediates the actions of numerous cytokines and growth factors, and its endogenous brake is the family of SOCS proteins. Consistent with their intracellular roles, SOCS proteins have never been identified in the extracellular space. Here we report that alveolar macrophages can secrete SOCS1 and -3 in exosomes and microparticles, respectively, for uptake by alveolar epithelial cells and subsequent inhibition of STAT activation. Secretion is tunable and occurs both in vitro and in vivo. SOCS secretion into lung lining fluid was diminished by cigarette smoking in humans and mice. Secretion and transcellular delivery of vesicular SOCS proteins thus represent a new model for the control of inflammatory signaling, which is subject to dysregulation during states of inflammation.

13 March 2013 in Nature
Verified
Journal Article
Open access
PDF file
JHJonathan Hoggatt
Jonathan Hoggatt
KMKhalid S. Mohammad
Khalid S. Mohammad
PSPratibha Singh
Pratibha Singh
AHAmber F. Hoggatt
Amber F. Hoggatt
BCBrahmananda R. Chitteti
Brahmananda R. Chitteti
LPLouis M. Pelus
Louis M. Pelus
Endogenous prostaglandin E2 (PGE2) is a potent regulator of haematopoietic stem cell (HSC) retention in the bone marrow; inhibition of endogenous PGE2 signalling by non-steroidal anti-inflammatory drugs results in enhanced HSC and haematopoietic progenitor cell mobility via E-prostanoid 4 (EP4) receptor antagonism. The haematopoietic stem cell (HSC) microenvironment supports progenitor cells producing new circulating blood cells yet prevents the inappropriate exit of immature cells into the bloodstream. This study identifies endogenous prostaglandin E2 (PGE2) as a component in the maintenance of this delicate balance. Louis M. Pelus and colleagues show that inhibition of endogenous PGE2 signalling by nonsteroidal anti-inflammatory drugs (NSAIDs) significantly increases the release of functional haematopoietic stem and progenitors from bone marrow into the peripheral blood, with additive effects when used in conjunction with granulocyte colony-stimulating factor. Tests in primates and human volunteers suggest a strategy that might be used therapeutically to enhance transplantation survival: administration of NSAIDs (aspirin, ibuprofen and meloxicam) enhances stem-cell mobilization, with faster haematologic recovery and enhanced long-term stem-cell repopulation of haematopoietic grafts. To maintain lifelong production of blood cells, haematopoietic stem cells (HSCs) are tightly regulated by inherent programs and extrinsic regulatory signals received from their microenvironmental niche. Long-term repopulating HSCs reside in several, perhaps overlapping, niches that produce regulatory molecules and signals necessary for homeostasis and for increased output after stress or injury1,2,3,4,5. Despite considerable advances in the specific cellular or molecular mechanisms governing HSC–niche interactions, little is known about the regulatory function in the intact mammalian haematopoietic niche. Recently, we and others described a positive regulatory role for prostaglandin E2 (PGE2) on HSC function ex vivo6,7. Here we show that inhibition of endogenous PGE2 by non-steroidal anti-inflammatory drug (NSAID) treatment in mice results in modest HSC egress from the bone marrow. Surprisingly, this was independent of the SDF-1–CXCR4 axis implicated in stem-cell migration. Stem and progenitor cells were found to have differing mechanisms of egress, with HSC transit to the periphery dependent on niche attenuation and reduction in the retentive molecule osteopontin. Haematopoietic grafts mobilized with NSAIDs had superior repopulating ability and long-term engraftment. Treatment of non-human primates and healthy human volunteers confirmed NSAID-mediated egress in other species. PGE2 receptor knockout mice demonstrated that progenitor expansion and stem/progenitor egress resulted from reduced E-prostanoid 4 (EP4) receptor signalling. These results not only uncover unique regulatory roles for EP4 signalling in HSC retention in the niche, but also define a rapidly translatable strategy to enhance transplantation therapeutically.

7 May 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LPLoka Raghu Kumar Penke
Loka Raghu Kumar Penke
JSJennifer Speth
Jennifer Speth
VDVijaya L. Dommeti
Vijaya L. Dommeti
EWEric S. White
Eric S. White
IBIngrid L. Bergin
Ingrid L. Bergin
MPMarc Peters-Golden
Marc Peters-Golden
While the transcription factor forkhead box M1 (FOXM1) is well known as a proto-oncogene, its potential role in lung fibroblast activation has never been explored. Here, we show that FOXM1 is more highly expressed in fibrotic than in normal lung fibroblasts in humans and mice. FOXM1 was required not only for cell proliferation in response to mitogens, but also for myofibroblast differentiation and apoptosis resistance elicited by TGF-β. The lipid mediator PGE2, acting via cAMP signaling, was identified as an endogenous negative regulator of FOXM1. Finally, genetic deletion of FOXM1 in fibroblasts or administration of the FOXM1 inhibitor Siomycin A in a therapeutic protocol attenuated bleomycin-induced pulmonary fibrosis. Our results identify FOXM1 as a driver of lung fibroblast activation and underscore the therapeutic potential of targeting FOXM1 for pulmonary fibrosis.

1 December 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DSDaniel J. Schneider
Daniel J. Schneider
JSJennifer Speth
Jennifer Speth
LPLoka Raghu Kumar Penke
Loka Raghu Kumar Penke
SWScott H. Wettlaufer
Scott H. Wettlaufer
JSJoel A. Swanson
Joel A. Swanson
MPMarc Peters-Golden
Marc Peters-Golden
Extracellular vesicles, including exosomes and shed microvesicles (MVs), can be internalized by recipient cells to modulate function. Although the mechanism by which extracellular vesicles are internalized is incompletely characterized, it is generally considered to involve endocytosis and an initial surface-binding event. Furthermore, modulation of uptake by microenvironmental factors is largely unstudied. Here, we used flow cytometry, confocal microscopy, and pharmacologic and molecular targeting to address these gaps in knowledge in a model of pulmonary alveolar cell-cell communication. Alveolar macrophage–derived MVs were fully internalized by alveolar epithelial cells in a time-, dose-, and temperature-dependent manner. Uptake was dependent on dynamin and actin polymerization. However, it was neither saturable nor dependent on clathrin or receptor binding. Internalization was enhanced by extracellular proteins but was inhibited by cigarette smoke extract via oxidative disruption of actin polymerization. We conclude that MV internalization occurs via a pathway more consistent with fluid-phase than receptor-dependent endocytosis and is subject to bidirectional modulation by relevant pathologic perturbations.

6 February 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CDChristina Draijer
Christina Draijer
JSJennifer Speth
Jennifer Speth
LPLoka Raghu Kumar Penke
Loka Raghu Kumar Penke
ZZZbigniew Zaslona
Zbigniew Zaslona
JBJoseph D. Bazzill
Joseph D. Bazzill
MPMarc Peters-Golden
Marc Peters-Golden
Resident alveolar macrophages (AMs) suppress allergic inflammation in murine asthma models. Previously we reported that resident AMs can blunt inflammatory signaling in alveolar epithelial cells (ECs...